Overview

The Dublin Zepatier Study

Status:
Terminated
Trial end date:
2019-12-06
Target enrollment:
Participant gender:
Summary
Evaluation of Zepatier in a community-based setting among cirrhotic and non-cirrhotic patients on stable opiate substitution therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Mater Misericordiae University Hospital
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Elbasvir-grazoprevir drug combination